Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Equity Ratio (2016 - 2026)

Iradimed has reported Equity Ratio over the past 14 years, most recently at 0.86 for Q1 2026.

  • Quarterly Equity Ratio fell 2.71% to 0.86 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.86 through Mar 2026, down 2.71% year-over-year, with the annual reading at 0.87 for FY2025, 1.49% down from the prior year.
  • Equity Ratio was 0.86 for Q1 2026 at Iradimed, down from 0.87 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.89 in Q2 2025 and troughed at 0.77 in Q4 2023.
  • The 5-year median for Equity Ratio is 0.86 (2024), against an average of 0.86.
  • Year-over-year, Equity Ratio decreased 10.05% in 2023 and then grew 13.93% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.86 in 2022, then decreased by 10.05% to 0.77 in 2023, then rose by 13.93% to 0.88 in 2024, then dropped by 1.49% to 0.87 in 2025, then dropped by 0.99% to 0.86 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Equity Ratio are 0.86 (Q1 2026), 0.87 (Q4 2025), and 0.86 (Q3 2025).